176 related articles for article (PubMed ID: 34785925)
21. Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells.
Hellsten R; Johansson M; Dahlman A; Sterner O; Bjartell A
PLoS One; 2011; 6(7):e22118. PubMed ID: 21779382
[TBL] [Abstract][Full Text] [Related]
22. Two novel SHP-1 agonists, SC-43 and SC-78, are more potent than regorafenib in suppressing the in vitro stemness of human colorectal cancer cells.
Chung SY; Chen YH; Lin PR; Chao TC; Su JC; Shiau CW; Su Y
Cell Death Discov; 2018; 4():25. PubMed ID: 30109144
[TBL] [Abstract][Full Text] [Related]
23. Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling.
To NB; Nguyen YT; Moon JY; Ediriweera MK; Cho SK
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32503225
[TBL] [Abstract][Full Text] [Related]
24. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
25. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
[TBL] [Abstract][Full Text] [Related]
26. The Differential Antitumor Activity of 5-Aza-2'-deoxycytidine in Prostate Cancer DU145, 22RV1, and LNCaP Cells.
Cheng H; Tang S; Lian X; Meng H; Gu X; Jiang J; Li X
J Cancer; 2021; 12(18):5593-5604. PubMed ID: 34405020
[TBL] [Abstract][Full Text] [Related]
27. Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6/STAT3 pathway.
Cao H; Feng Y; Sun P; Chen L; Wang D; Gao R
J Cancer; 2023; 14(12):2246-2254. PubMed ID: 37576403
[No Abstract] [Full Text] [Related]
28. The same and not the same: heterogeneous functional activation of prostate tumor cells by TLR ligation.
Rezania S; Amirmozaffari N; Rashidi N; Mirzadegan E; Zarei S; Ghasemi J; Zarei O; Katouzian L; Zarnani AH
Cancer Cell Int; 2014; 14():54. PubMed ID: 24966802
[TBL] [Abstract][Full Text] [Related]
29. ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro.
Yu D; Zhong Y; Li X; Li Y; Li X; Cao J; Fan H; Yuan Y; Ji Z; Qiao B; Wen JG; Zhang M; Kvalheim G; Nesland JM; Suo Z
Oncotarget; 2015 Dec; 6(40):42687-703. PubMed ID: 26528857
[TBL] [Abstract][Full Text] [Related]
30. Lipopolysaccharide induces epithelial-mesenchymal transition of alveolar epithelial cells cocultured with macrophages possibly via the JAK2/STAT3 signaling pathway.
Qin Y; Zhao P; Chen Y; Liu X; Dong H; Zheng W; Li C; Mao X; Li J
Hum Exp Toxicol; 2020 Feb; 39(2):224-234. PubMed ID: 31610697
[TBL] [Abstract][Full Text] [Related]
31. Adipocytes reprogram prostate cancer stem cell machinery.
Fontana F; Anselmi M; Limonta P
J Cell Commun Signal; 2023 Sep; 17(3):915-924. PubMed ID: 36940071
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
Xiang S; Dong NG; Liu JP; Wang Y; Shi JW; Wei ZJ; Hu XJ; Gong L
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
[TBL] [Abstract][Full Text] [Related]
33. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
34. Oct4 downregulation-induced inflammation increases the migration and invasion rate of oral squamous cell carcinoma.
Sun S; Yang H; Wang F; Zhao S
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1440-1449. PubMed ID: 34553218
[TBL] [Abstract][Full Text] [Related]
35. [Effects of ascites derived exosomes on the stemness and invasion ability of ovarian cancer stem-like cell].
Chen SP; Xia YF; Jiang HH; Sun WY; Lou YH
Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):349-357. PubMed ID: 34034422
[No Abstract] [Full Text] [Related]
36. MACC1 regulates the AKT/STAT3 signaling pathway to induce migration, invasion, cancer stemness, and suppress apoptosis in cervical cancer cells.
Mei J; Zhu C; Pan L; Li M
Bioengineered; 2022 Jan; 13(1):61-70. PubMed ID: 34939526
[TBL] [Abstract][Full Text] [Related]
37. 2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells.
Li W; Zhang Q; Chen K; Sima Z; Liu J; Yu Q; Liu J
BMC Complement Altern Med; 2019 Feb; 19(1):38. PubMed ID: 30709346
[TBL] [Abstract][Full Text] [Related]
38. Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells.
Wang X; Xu J; Wang H; Wu L; Yuan W; Du J; Cai S
Biochem Biophys Res Commun; 2015 Jan; 456(1):320-6. PubMed ID: 25434997
[TBL] [Abstract][Full Text] [Related]
39. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
[No Abstract] [Full Text] [Related]
40. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
